Index tracked: MSCI USA Quality Advanced Target Select 100% Hedged to CHF Index (Net Total Return)
TER
0.28%+ trans. 0.00%
Fund size
—
Tracking difference
—not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 25 Apr 2023 · costs from the KID as of 26 Aug 2026
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Il Fondo è gestito in modo passivo e acquisirà un'esposizione proporzionale nelle componenti del MSCI USA Quality Advanced Target Select 100% Hedged to CHF Index (Net Total Return) tramite investimenti diretti in tutti o praticamente tutti i titoli e/o mediante l'impiego di strumenti derivati, in particolare nei casi in cui non è possibile o praticabile replicare l'indice attraverso investimenti diretti oppure allo scopo di generare efficienze nell'acquisizione di esposizione all'indice. In alcuni casi il comparto potrebbe anche detenere titoli non…
Performance since series start (in euro) — base 100
25 Apr 2023 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
High 184 (27 Aug 2026) · low 99 (26 Apr 2023) · last 178. Past performance is not indicative of future results.
The live sheet, always up to date rebalix.com/en/etf/IE000S9T0WR9 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.